Pacira Pharmaceuticals makes appointments
This article was originally published in Scrip
Pacira Pharmaceuticals(US), an acute care speciality pharmaceutical company, has appointed Dr Gary Pace to its board of directors. Dr Pace is the founder and past chairman and CEO of QRx Pharma, and has also director and chairman positions for several speciality pharmaceutical companies. Pacira has also named Dr Bill Kirkpatrick, who has 30 years' medical regulatory and quality assurance experience, vice-president of compliance.
You may also be interested in...
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.
A lower first dose boosted the vaccine’s efficacy result, but AstraZeneca has conceded that this has to be proven in a separate trial. In the meantime, the UK government has asked the regulator to assess the vaccine under a special health emergency provision.